![A five-way crossover study to evaluate the single-dose effects of a novel 5-HT6 receptor antagonist, PF-07212377 (SAM-760), on reversing psychomotor and cognitive deficits induced by scopolamine]()
A five-way crossover study to evaluate the single-dose effects of a novel 5-HT6 receptor antagonist, PF-07212377 (SAM-760), on reversing psychomotor and cognitive deficits induced by scopolamineBell, Joanne M.; Comery, Thomas A.; Lockwood, Peter; Huang, Yifan; Vandal, Grace; Maruff, Paul; Kupiec, James · Alzheimer's & Dementia · 2012